STAAR Surgical Company (STAA)

Currency in USD
32.47
-0.32(-0.98%)
Closed·
32.50+0.03(+0.09%)
·
STAA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
32.4733.32
52 wk Range
15.5935.87
Key Statistics
Prev. Close
32.79
Open
32.72
Day's Range
32.47-33.32
52 wk Range
15.59-35.87
Volume
738.73K
Average Volume (3m)
1.29M
1-Year Change
73.8223%
Book Value / Share
7.12
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
STAA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
29.67
Downside
-8.63%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings upwards for the upcoming period

STAAR Surgical Company News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Analyst Ratings

3 Buy
8 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 29.67
(-8.63% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Piper Sandler
Hold33.00+1.63%16.00MaintainMay 14, 2026
Wedbush
Buy40.00+23.19%-UpgradeMay 14, 2026
Canaccord
Buy32.00-1.45%27.00MaintainMay 14, 2026
Mizuho
Hold27.00-16.85%22.00MaintainMay 14, 2026
Stifel
Hold31.00-4.53%18.00MaintainMay 14, 2026

STAAR Surgical Company Earnings Call Summary for Q1/2026

  • STAAR Surgical Q1 2026 EPS of $0.10 doubled forecasts; revenue hit $93.5M, up 119.6% YoY, beating estimates by 18.75%.
  • China sales drove growth at $47.4M; U.S. market exceeded $6M quarterly for first time; gross margin improved to 73.6% from 65.8%.
  • Adjusted EBITDA turned positive at $24.4M vs. $26.3M loss last year; operating income reached $8.0M from $57.4M loss in Q1 2025.
  • Stock rose 4.33% to $28.21 after-hours; company forecasts Q2 2026 EPS of $0.17, full-year EPS of $0.47, and Q2 revenue of $84M.
  • CEO Mason emphasized strategic focus on China and U.S. expansion; risks include economic conditions, regulatory changes, and currency fluctuations.
Last Updated: 2026-05-13, 06:34 p/m
Read Full Transcript

Earnings

Latest Release
May 13, 2026
EPS / Forecast
0.10 / 0.05
Revenue / Forecast
93.5M / 78.74M
EPS Revisions
Last 90 days

STAA Income Statement

Compare STAA to Peers and Sector

Metrics to compare
STAA
Peers
Sector
Relationship
P/E Ratio
−76.9x−1.7x−0.5x
PEG Ratio
−1.11−0.160.00
Price/Book
4.6x4.3x2.6x
Price / LTM Sales
5.6x2.7x3.1x
Upside (Analyst Target)
−12.3%51.4%53.0%
Fair Value Upside
Unlock14.9%6.3%Unlock

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
14.92M29.97%484.45M
Other Institutional Investors
60.82M70.03%1.97B
Public Companies & Retail Investors
0.000.00%0.00
Total
75.74M100.00%2.46B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Broadwood Partners LP32.38%16,123,842523,541
Broadwood Capital, Inc.32.38%16,123,842523,541

People Also Watch

16.350
AVTX
-1.51%
61.39
BAND
+4.87%
86.80
VLTO
+0.98%
2.000
ALLO
+2.04%
53.0100
SLNO
+0.04%

FAQ

What Is the STAAR Surgical (STAA) Stock Price Today?

The STAAR Surgical stock price today is 32.47 USD.

What Stock Exchange Does STAAR Surgical Trade On?

STAAR Surgical is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for STAAR Surgical?

The stock symbol for STAAR Surgical is "STAA."

What Is the STAAR Surgical Market Cap?

As of today, STAAR Surgical market cap is 1.62B USD.

What Is STAAR Surgical's Earnings Per Share (TTM)?

The STAAR Surgical EPS (TTM) is -0.42.

When Is the Next STAAR Surgical Earnings Date?

STAAR Surgical will release its next earnings report on Aug 12, 2026.

From a Technical Analysis Perspective, Is STAA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has STAAR Surgical Stock Split?

STAAR Surgical has split 1 times.

How Many Employees Does STAAR Surgical Have?

STAAR Surgical has 921 employees.

What is the current trading status of STAAR Surgical (STAA)?

As of May 23, 2026, STAAR Surgical (STAA) is trading at a price of 32.47 USD, with a previous close of 32.79 USD. The stock has fluctuated within a day range of 32.47 USD to 33.32 USD, while its 52-week range spans from 15.59 USD to 35.87 USD.

What Is STAAR Surgical (STAA) Price Target According to Analysts?

The average 12-month price target for STAAR Surgical is 29.67 USD, with a high estimate of 40 USD and a low estimate of 23 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an -8.63% Downside potential.

What Is the STAA Premarket Price?

STAA's last pre-market stock price is 32.15 USD. The pre-market share volume is 1,100.00, and the stock has decreased by -0.64, or -1.95%.

What Is the STAA After Hours Price?

STAA's last after hours stock price is 32.50 USD, the stock has decreased by 0.03, or 0.09%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.